{"transactions":[{"id":754315,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:20:59.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001191235-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000119123526000003/primarydocument.xml","form_type":"4"}},{"id":754314,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:20:59.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001191235-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000119123526000003/primarydocument.xml","form_type":"4"}},{"id":770370,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:13:33.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":4.52,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001191235-26-000002","document":"wk-form4_1779308010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000119123526000002/wk-form4_1779308010.xml","form_type":"4"}},{"id":770369,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:13:33.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001191235-26-000002","document":"wk-form4_1779308010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000119123526000002/wk-form4_1779308010.xml","form_type":"4"}},{"id":770368,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:13:33.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001191235-26-000002","document":"wk-form4_1779308010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000119123526000002/wk-form4_1779308010.xml","form_type":"4"}},{"id":770367,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:13:33.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14750,"source":{"system":"sec-edgar","filing":"0001191235-26-000002","document":"wk-form4_1779308010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000119123526000002/wk-form4_1779308010.xml","form_type":"4"}},{"id":1124520,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:33:07.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004352","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218025004352/primarydocument.xml","form_type":"4"}},{"id":1124519,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:33:07.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004352","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218025004352/primarydocument.xml","form_type":"4"}},{"id":1137741,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T20:02:36.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":1.49,"expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001125345-25-000081","document":"wk-form4_1747944148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000081/wk-form4_1747944148.xml","form_type":"4"}},{"id":1137740,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T20:02:36.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001125345-25-000081","document":"wk-form4_1747944148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000081/wk-form4_1747944148.xml","form_type":"4"}},{"id":1137739,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T20:02:36.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001125345-25-000081","document":"wk-form4_1747944148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000081/wk-form4_1747944148.xml","form_type":"4"}},{"id":1137738,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:02:36.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":true,"shares":6500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001125345-25-000081","document":"wk-form4_1747944148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000081/wk-form4_1747944148.xml","form_type":"4"}},{"id":1491772,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:39:46.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":24454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":24454,"derivative":{"exercise_price":14.35,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":24454},"source":{"system":"sec-edgar","filing":"0001562180-24-004649","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218024004649/primarydocument.xml","form_type":"4"}},{"id":1491771,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:39:46.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-004649","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218024004649/primarydocument.xml","form_type":"4"}},{"id":1504083,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T21:16:58.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":4.26,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001125345-24-000129","document":"wk-form4_1716499006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000129/wk-form4_1716499006.xml","form_type":"4"}},{"id":1504082,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-23T21:16:58.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":6500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001125345-24-000129","document":"wk-form4_1716499006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000129/wk-form4_1716499006.xml","form_type":"4"}},{"id":1505899,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-22T20:33:58.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001125345-24-000106","document":"wk-form4_1716410028.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000106/wk-form4_1716410028.xml","form_type":"4"}},{"id":1505898,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:33:58.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001125345-24-000106","document":"wk-form4_1716410028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000106/wk-form4_1716410028.xml","form_type":"4"}},{"id":1864959,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-06T21:12:48.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer."}],"balance_after":17892,"derivative":{"exercise_price":19.72,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001562180-23-004893","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218023004893/primarydocument.xml","form_type":"4"}},{"id":1864958,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:12:48.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer."}],"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001562180-23-004893","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218023004893/primarydocument.xml","form_type":"4"}},{"id":1870557,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:54:46.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":4500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001125345-23-000096","document":"wk-form4_1685739273.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000096/wk-form4_1685739273.xml","form_type":"4"}},{"id":1870556,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:54:46.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":19000,"derivative":{"exercise_price":4.67,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001125345-23-000096","document":"wk-form4_1685739273.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000096/wk-form4_1685739273.xml","form_type":"4"}},{"id":2240003,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:22:20.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":15324,"derivative":{"exercise_price":22.84,"expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":15324},"source":{"system":"sec-edgar","filing":"0001562180-22-004880","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218022004880/primarydocument.xml","form_type":"4"}},{"id":2240002,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:22:20.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001562180-22-004880","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218022004880/primarydocument.xml","form_type":"4"}},{"id":2260432,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T01:07:58.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":18000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001125345-22-000068","document":"wf-form4_165335446035323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000068/wf-form4_165335446035323.xml","form_type":"4"}},{"id":2677201,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:21:03.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following June 4, 2021."}],"balance_after":10000,"derivative":{"exercise_price":35.52,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-21-004130","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218021004130/primarydocument.xml","form_type":"4"}},{"id":2710614,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T01:30:09.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":28.88,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001125345-21-000076","document":"wf-form4_162130139081001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534521000076/wf-form4_162130139081001.xml","form_type":"4"}},{"id":3091379,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:40:27.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":44991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44991},"source":{"system":"sec-edgar","filing":"0001209191-20-040371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040371/doc4.xml","form_type":"4"}},{"id":3091378,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:40:27.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":11377,"price":0.06,"value":682.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law."}],"balance_after":0,"derivative":{"exercise_price":17.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":11377},"source":{"system":"sec-edgar","filing":"0001209191-20-040371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040371/doc4.xml","form_type":"4"}},{"id":3091377,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-02T16:40:27.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":7281,"price":18,"value":131058.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"At the Effective Time, each restricted stock unit (\"RSU\") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040371/doc4.xml","form_type":"4"}},{"id":3091376,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T16:40:27.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":13194,"price":18,"value":237492.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the \"Issuer\"), Alexion\nPharmaceuticals, Inc. (\"Alexion\") and Odyssey Merger Sub Inc. (\"Merger Sub\") (the \"Merger Agreement\"), on July 2, 2020, Merger Sub merged with and\ninto the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the \"Merger\"). At the\neffective time of the Merger (the \"Effective Time\"), these shares were canceled in exchange for $18.00 per share in cash, without interest and\nsubject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040371/doc4.xml","form_type":"4"}},{"id":3095562,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-01T16:39:22.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.2634,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-018122","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924320018122/doc4.xml","form_type":"4"}},{"id":3110384,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T19:15:43.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":11377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":11377,"derivative":{"exercise_price":17.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":11377},"source":{"system":"sec-edgar","filing":"0001209191-20-036792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120036792/doc4.xml","form_type":"4"}},{"id":3110383,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T19:15:43.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":7281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\") in consideration of services rendered. The RSUs fully vest on March 1, 2021, subject to the Reporting Person's Continuous Services (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":20475,"source":{"system":"sec-edgar","filing":"0001209191-20-036792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120036792/doc4.xml","form_type":"4"}},{"id":3126643,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:36:16.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":37.66,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004070","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218020004070/primarydocument.xml","form_type":"4"}},{"id":3147542,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-15T20:38:09.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":24.97,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001125345-20-000093","document":"wf-form4_158957507216789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534520000093/wf-form4_158957507216789.xml","form_type":"4"}},{"id":3472066,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-02T17:21:23.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.7268,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-018922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924319018922/doc4.xml","form_type":"4"}},{"id":3487529,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T17:36:43.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":6991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6991,"derivative":{"exercise_price":26.09,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":6991},"source":{"system":"sec-edgar","filing":"0001209191-19-037467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119037467/doc4.xml","form_type":"4"}},{"id":3487528,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T17:36:43.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":4194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\") in consideration of services rendered. The RSUs fully vest on March 1, 2020, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":13194,"source":{"system":"sec-edgar","filing":"0001209191-19-037467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119037467/doc4.xml","form_type":"4"}},{"id":3501952,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:23:29.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 31, 2019."}],"balance_after":10000,"derivative":{"exercise_price":43.02,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003296","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218019003296/primarydocument.xml","form_type":"4"}},{"id":3518852,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-20T21:48:26.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":18,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-19-000074","document":"wf-form4_155838889000225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000074/wf-form4_155838889000225.xml","form_type":"4"}},{"id":3876250,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-03T20:01:02.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.12,"expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-18-009425","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000117911018009425/edgar.xml","form_type":"4"}},{"id":3899791,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T18:23:38.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6000,"derivative":{"exercise_price":42.81,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-036770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919118036770/doc4.xml","form_type":"4"}},{"id":3899790,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T18:23:38.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSU\") in consideration of services rendered. The RSUs fully vest on March 1, 2019, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-18-036770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919118036770/doc4.xml","form_type":"4"}},{"id":3913901,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T20:34:36.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 25, 2018."}],"balance_after":12500,"derivative":{"exercise_price":49.45,"expiration_date":"2028-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-002718","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000156218018002718/primarydocument.xml","form_type":"4"}},{"id":3924228,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T20:53:34.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":21.34,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-18-000070","document":"wf-form4_152693600090813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534518000070/wf-form4_152693600090813.xml","form_type":"4"}},{"id":4277279,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-19T18:20:23.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest each month after June 1, 2017, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6000,"derivative":{"exercise_price":35.06,"expiration_date":"2027-06-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-040926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919117040926/doc4.xml","form_type":"4"}},{"id":4277278,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-19T18:20:23.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSU\") in consideration of services rendered. The RSUs fully vest on March 1, 2018, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-17-040926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919117040926/doc4.xml","form_type":"4"}},{"id":4296395,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T17:43:28.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over one (1) year in equal monthly installments from the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":2.96,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-17-008462","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000117911017008462/edgar.xml","form_type":"4"}},{"id":4302738,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T21:00:32.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 24, 2017."}],"balance_after":12500,"derivative":{"exercise_price":18.85,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-17-014568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191235/000089924317014568/doc4.xml","form_type":"4"}},{"id":4310245,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":42345,"kind":"person","name":"STUMP DAVID C","position":1,"cik":"0001191235","reported_name":"STUMP DAVID C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-22T23:02:38.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":19.57,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-17-000079","document":"wf-form4_149549414384083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000079/wf-form4_149549414384083.xml","form_type":"4"}}]}